Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Thrombocytopenia 2Leukemia, Myeloid, Acute 2Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Hematologic Neoplasms 1Congenital Abnormalities 1Bone Marrow Failure Disorders 1

Interventions

Cytarabine 3Microarray Analysis 2midostaurin 1laromustine 1eltrombopag 1dexamethasone acetate 1Reverse Transcriptase Polymerase Chain Reaction 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Idarubicin 1Genetic Testing 1Gene Expression Profiling 1Gemtuzumab 1Daunorubicin 1DNA Methylation 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Basophilic, Acute × eltrombopag × Clear all
NCT02071901 2021-12-01

Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

Case Comprehensive Cancer Center

Phase 2 Unknown
31 enrolled 14 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡